Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin-Chi Chen

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Cancer|October 6, 2010
Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancerKaren Reckamp, Barbara Gitlitz, Lin-Chi Chen, et al.
Investigational New Drugs|February 6, 2020
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemiaGeoffrey L Uy, Sarit Assouline, Anne-Marie Young, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2019
A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [<sup>14</sup>C]-labeled idasanutlin and an intravenous tracer dose of [<sup>13</sup>C]-labeled idasanutlin in a single cohort of patients with solid tumorsZsuzsanna Pápai, Lin-Chi Chen, Daniel Da Costa, et al.
Biosensors & Bioelectronics|May 15, 2004
Amperometric detection of morphine at a Prussian blue-modified indium tin oxide electrodeKuo-Chuan Ho, Chia-Yi Chen, Huan-Cheng Hsu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 22, 2009
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancerLin-Chi Chen, Andrew B Brown, Irene Y Cheung, et al.
ACS Applied Materials & Interfaces|April 22, 2016
Signal-on Protein Detection via Dye Translocation between Aptamer and Quantum DotYeh-Hsing Lao, Chun-Wei Chi, Sarah M Friedrich, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2018
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumorsJohn Nemunaitis, Annie Young, Samuel Ejadi, et al.
Investigational New Drugs|November 18, 2019
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumorsAlbiruni R Abdul Razak, Wilson H Miller, Geoffrey L Uy, et al.
Chemical Communications (Cambridge, England)|June 20, 2012
Nanoporous carbons through direct carbonization of a zeolitic imidazolate framework for supercapacitor electrodesWatcharop Chaikittisilp, Ming Hu, Hongjing Wang, et al.
Biosensors & Bioelectronics|August 4, 2019
Spectral contrast imaging method for mapping transmission surface plasmon images in metallic nanostructuresMing-Yang Pan, Deng-Kai Yang, Chih-Yu Lai, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cancer|October 6, 2010
Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancerKaren Reckamp, Barbara Gitlitz, Lin-Chi Chen, et al.
Investigational New Drugs|February 6, 2020
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemiaGeoffrey L Uy, Sarit Assouline, Anne-Marie Young, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2019
A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [<sup>14</sup>C]-labeled idasanutlin and an intravenous tracer dose of [<sup>13</sup>C]-labeled idasanutlin in a single cohort of patients with solid tumorsZsuzsanna Pápai, Lin-Chi Chen, Daniel Da Costa, et al.
Biosensors & Bioelectronics|May 15, 2004
Amperometric detection of morphine at a Prussian blue-modified indium tin oxide electrodeKuo-Chuan Ho, Chia-Yi Chen, Huan-Cheng Hsu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 22, 2009
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancerLin-Chi Chen, Andrew B Brown, Irene Y Cheung, et al.
ACS Applied Materials & Interfaces|April 22, 2016
Signal-on Protein Detection via Dye Translocation between Aptamer and Quantum DotYeh-Hsing Lao, Chun-Wei Chi, Sarah M Friedrich, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2018
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumorsJohn Nemunaitis, Annie Young, Samuel Ejadi, et al.
Investigational New Drugs|November 18, 2019
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumorsAlbiruni R Abdul Razak, Wilson H Miller, Geoffrey L Uy, et al.
Chemical Communications (Cambridge, England)|June 20, 2012
Nanoporous carbons through direct carbonization of a zeolitic imidazolate framework for supercapacitor electrodesWatcharop Chaikittisilp, Ming Hu, Hongjing Wang, et al.
Biosensors & Bioelectronics|August 4, 2019
Spectral contrast imaging method for mapping transmission surface plasmon images in metallic nanostructuresMing-Yang Pan, Deng-Kai Yang, Chih-Yu Lai, et al.
Pageof 5